These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 12885891

  • 1. Induction of protective immune responses against R5 human immunodeficiency virus type 1 (HIV-1) infection in hu-PBL-SCID mice by intrasplenic immunization with HIV-1-pulsed dendritic cells: possible involvement of a novel factor of human CD4(+) T-cell origin.
    Yoshida A, Tanaka R, Murakami T, Takahashi Y, Koyanagi Y, Nakamura M, Ito M, Yamamoto N, Tanaka Y.
    J Virol; 2003 Aug; 77(16):8719-28. PubMed ID: 12885891
    [Abstract] [Full Text] [Related]

  • 2. Identification of HIV-1 epitopes that induce the synthesis of a R5 HIV-1 suppression factor by human CD4+ T cells isolated from HIV-1 immunized hu-PBL SCID mice.
    Yoshida A, Tanaka R, Kodama A, Yamamoto N, Ansari AA, Tanaka Y.
    Clin Dev Immunol; 2005 Dec; 12(4):235-42. PubMed ID: 16584108
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice.
    Santini SM, Lapenta C, Logozzi M, Parlato S, Spada M, Di Pucchio T, Belardelli F.
    J Exp Med; 2000 May 15; 191(10):1777-88. PubMed ID: 10811870
    [Abstract] [Full Text] [Related]

  • 7. T-cell dysfunctions in hu-PBL-SCID mice infected with human immunodeficiency virus (HIV) shortly after reconstitution: in vivo effects of HIV on highly activated human immune cells.
    Rizza P, Santini SM, Logozzi MA, Lapenta C, Sestili P, Gherardi G, Lande R, Spada M, Parlato S, Belardelli F, Fais S.
    J Virol; 1996 Nov 15; 70(11):7958-64. PubMed ID: 8892919
    [Abstract] [Full Text] [Related]

  • 8. High titer, prostate specific antigen-specific human IgG production by hu-PBL-SCID mice immunized with antigen-mouse IgG2a complex-pulsed autologous dendritic cells.
    Coccia MA, Brams P.
    J Immunol; 1998 Nov 15; 161(10):5772-80. PubMed ID: 9820559
    [Abstract] [Full Text] [Related]

  • 9. The human HIV/peripheral blood lymphocyte (PBL)-SCID mouse. A modified human PBL-SCID model for the study of HIV pathogenesis and therapy.
    Boyle MJ, Connors M, Flanigan ME, Geiger SP, Ford H, Baseler M, Adelsberger J, Davey RT, Lane HC.
    J Immunol; 1995 Jun 15; 154(12):6612-23. PubMed ID: 7759895
    [Abstract] [Full Text] [Related]

  • 10. IFN-alpha-conditioned dendritic cells are highly efficient in inducing cross-priming CD8(+) T cells against exogenous viral antigens.
    Lapenta C, Santini SM, Spada M, Donati S, Urbani F, Accapezzato D, Franceschini D, Andreotti M, Barnaba V, Belardelli F.
    Eur J Immunol; 2006 Aug 15; 36(8):2046-60. PubMed ID: 16856207
    [Abstract] [Full Text] [Related]

  • 11. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.
    Zitvogel L, Mayordomo JI, Tjandrawan T, DeLeo AB, Clarke MR, Lotze MT, Storkus WJ.
    J Exp Med; 1996 Jan 01; 183(1):87-97. PubMed ID: 8551248
    [Abstract] [Full Text] [Related]

  • 12. A Simple Mouse Model for the Study of Human Immunodeficiency Virus.
    Kim KC, Choi BS, Kim KC, Park KH, Lee HJ, Cho YK, Kim SI, Kim SS, Oh YK, Kim YB.
    AIDS Res Hum Retroviruses; 2016 Feb 01; 32(2):194-202. PubMed ID: 26564392
    [Abstract] [Full Text] [Related]

  • 13. Type I interferon is a powerful inhibitor of in vivo HIV-1 infection and preserves human CD4(+) T cells from virus-induced depletion in SCID mice transplanted with human cells.
    Lapenta C, Santini SM, Proietti E, Rizza P, Logozzi M, Spada M, Parlato S, Fais S, Pitha PM, Belardelli F.
    Virology; 1999 Oct 10; 263(1):78-88. PubMed ID: 10544084
    [Abstract] [Full Text] [Related]

  • 14. hu-PBL-SCID mice can be protected from HIV-1 infection by passive transfer of monoclonal antibody to the principal neutralizing determinant of envelope gp120.
    Safrit JT, Fung MS, Andrews CA, Braun DG, Sun WN, Chang TW, Koup RA.
    AIDS; 1993 Jan 10; 7(1):15-21. PubMed ID: 7680205
    [Abstract] [Full Text] [Related]

  • 15. HIV-1 infection and CD4 T cell depletion in the humanized Rag2-/-gamma c-/- (RAG-hu) mouse model.
    Berges BK, Wheat WH, Palmer BE, Connick E, Akkina R.
    Retrovirology; 2006 Nov 01; 3():76. PubMed ID: 17078891
    [Abstract] [Full Text] [Related]

  • 16. Critical contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to apoptosis of human CD4+ T cells in HIV-1-infected hu-PBL-NOD-SCID mice.
    Miura Y, Misawa N, Maeda N, Inagaki Y, Tanaka Y, Ito M, Kayagaki N, Yamamoto N, Yagita H, Mizusawa H, Koyanagi Y.
    J Exp Med; 2001 Mar 05; 193(5):651-60. PubMed ID: 11238596
    [Abstract] [Full Text] [Related]

  • 17. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T, Iwahashi M, Nakamura M, Matsuda K, Naka T, Nakamori M, Ueda K, Ishida K, Yamaue H.
    Int J Oncol; 2006 Apr 05; 28(4):947-53. PubMed ID: 16525645
    [Abstract] [Full Text] [Related]

  • 18. Chimeric plant virus particles as immunogens for inducing murine and human immune responses against human immunodeficiency virus type 1.
    Marusic C, Rizza P, Lattanzi L, Mancini C, Spada M, Belardelli F, Benvenuto E, Capone I.
    J Virol; 2001 Sep 05; 75(18):8434-9. PubMed ID: 11507188
    [Abstract] [Full Text] [Related]

  • 19. Selective regulation of human immunodeficiency virus-infected CD4(+) lymphocytes by a synthetic immunomodulator leads to potent virus suppression in vitro and in hu-PBL-SCID mice.
    Bahr GM, Darcissac EC, Castéran N, Amiel C, Cocude C, Truong MJ, Dewulf J, Capron A, Mouton Y.
    J Virol; 2001 Aug 05; 75(15):6941-52. PubMed ID: 11435574
    [Abstract] [Full Text] [Related]

  • 20. Development of vaccines and passive immunotherapy against SARS coronavirus using mouse and SCID-PBL/hu mouse models.
    Okada M, Takemoto Y, Okuno Y, Hashimoto S, Fukunaga Y, Tanaka T, Kita Y, Kuwayama S, Muraki Y, Kanamaru N, Takai H, Okada C, Sakaguchi Y, Furukawa I, Yamada K, Izumiya M, Yoshida S, Matsumoto M, Kase T, Peiris JS, DeMello DE, Chen PJ, Yamamoto N, Yoshinaka Y, Nomura T, Ishida I, Morikawa S, Tashiro M, Sakatani M.
    Adv Exp Med Biol; 2006 Aug 05; 581():561-6. PubMed ID: 17037598
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.